Crispr Therapeutics shares owned by Vident Advisory
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Vident Advisory
from 13F filings
Historical chart of Vident Advisory investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Vident Advisory consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Vident Advisory
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $656k | 11k | 62.60 |
| 2023-09-30 | $460k | 10k | 45.39 |